This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
13 Sep 2013

Abcam Launches SimpleStep ELISA Kits

Abcam plc., a producer and distributor of high quality protein research tools, has launched a range of SimpleStep ELISA kits. The new kits have a greatly simplified protocol when compared with standard multi-step ELISAs, providing significant time savings and ease of use.

 

Offering enhanced performance, SimpleStep ELISA kits are single wash, colorimetric sandwich ELISAs that retain the familiar process and data outputs of a traditional ELISA kit. The kits require no specialised training or instrumentation and in contrast to standard ELISA achieve increased accuracy due to reduced sample handling steps. In addition, a more efficient in-solution binding process provides superior sensitivity and specificity.

 

The SimpleStep kits are ideal for studying intra- or extra- cellular signaling pathways or for cancer biomarker research. Numerous new kits are being added to the already extensive range each month. The kits are available in convenient off-the-shelf 1, 2, or 4 target conformation. Custom multi-target kits are also available, allowing customers to select analyte combinations specific to their research.

 

James Murray, General Manager, Abcam Eugene, commented: “Abcam is continually in touch with researchers to anticipate the latest research trends and developments, so that we can continue to meet their needs worldwide. We’re excited to see how SimpleStep ELISA kits will help to increase the pace of scientific discoveries.”

 

Developed and manufactured at Abcam’s laboratories, SimpleStep ELISAs have been extensively validated for specificity and sensitivity in a broad range of sample types and are accompanied by information-rich datasheets and expert scientific support. Addition of these kits enhances Abcam’s already extensive immunoassay portfolio consisting of 1600 products for the detection of more than 600 targets.

 

Related News